Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Schering_AG
|
| gptkbp:acquisition |
Boehringer Ingelheim's generic business in India
Unichem Laboratories' business in India |
| gptkbp:awards |
Various industry awards
|
| gptkbp:ceo |
Samir Mehta
|
| gptkbp:clinical_trial |
Conducts clinical trials
Phase I, II, III trials In-house clinical research |
| gptkbp:community_engagement |
gptkb:battle
|
| gptkbp:customer_base |
Healthcare providers
Hospitals Pharmacies |
| gptkbp:distribution |
Wide distribution network
|
| gptkbp:employees |
Over 10,000
|
| gptkbp:exported_to |
Over 40 countries
|
| gptkbp:financial_performance |
Publicly available financial reports
Consistent growth |
| gptkbp:founded |
gptkb:1959
|
| gptkbp:founder |
K. D. Rathi
|
| gptkbp:global_presence |
gptkb:battle
|
| gptkbp:governed_by |
Strong corporate governance practices
|
| gptkbp:headquarters |
gptkb:Ahmedabad,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Torrent Pharmaceuticals
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:invention |
Numerous patents filed
|
| gptkbp:investment |
New product development
Invests in R& D Expanding manufacturing capacity |
| gptkbp:market |
gptkb:India
gptkb:United_States |
| gptkbp:market_cap |
Approximately $3 billion (2020)
|
| gptkbp:marketing_strategy |
Focus on generics
Focus on specialty products |
| gptkbp:parent_company |
Torrent Group
|
| gptkbp:partnerships |
Academic institutions
Research organizations Various global pharmaceutical companies |
| gptkbp:product_line |
Pain management
Cardiovascular Nutraceuticals Diabetes care Anti-infectives |
| gptkbp:production_location |
Multiple locations in India
|
| gptkbp:products |
Branded drugs
Generic drugs |
| gptkbp:regulatory_compliance |
FDA approved
EMA approved |
| gptkbp:research |
Dr. R. S. Kharat
|
| gptkbp:research_and_development |
gptkb:battle
|
| gptkbp:research_areas |
gptkb:healthcare_organization
gptkb:hospital gptkb:Company Gastroenterology Urology Neurology |
| gptkbp:revenue |
$1 billion (2020)
|
| gptkbp:social_responsibility |
CSR initiatives
|
| gptkbp:stock_exchange |
gptkb:BSE
NSE |
| gptkbp:subsidiary |
Torrent Cables
Torrent Power |
| gptkbp:supply_chain |
Global supply chain
Efficient supply chain management |
| gptkbp:sustainability_initiatives |
gptkb:battle
|
| gptkbp:website |
www.torrentpharma.com
|